ClinicalTrials.gg
Active, not recruitingNCT07947459REMEDEUpdated Nov 19, 2026

Validation Study of Laparoscopic Intraoperative Ultrasound for Measuring Rectosigmoid Deep Infiltrating Endometriosis Nodules

An observational study in Endometriosis and Endometriosis Colon, sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Active, not recruiting at 1 site in Italy. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Observational

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 106 studies in Endometriosis with a site in Italy — 28 open to participants now, 34 under way, none of them phase 3. Endometriosis · Italy.

Planned enrollment
60th of 61
20 · median 200
Started
2026
with 5 others
Observational
61 of 106
20 open now
Primary completion
2027-12
later than 25 of 33 live
Registered
106th of 106
by date

Among the 106 studies in Endometriosis with a site in Italy, this one is the 60th largest by planned enrollment of the 61 observational ones that give a count, is one of 6 that started in 2026, is one of 61 observational ones, reaches primary completion later than 25 of the 33 other live ones, and was the 106th registered.

Endometriosis

924 studies on the registry are indexed under Endometriosis; 269 are open to participants now.

Browse Endometriosis studies →

Open to participants now

28 of the 106 studies in Endometriosis with a site in Italy are open now. Recruiting first, the newest first:

23 more — sign in →

All 28 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 180 Endometriosis studies recruiting now, 52 (29%) set no upper age limit and 126 (70%) stop at 75 or younger; 18 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 106 studies in Endometriosis with a site in Italy, or all of them as a file.
02

Study summary

The REMEDE study, a single-center retrospective and prospective observational study conducted at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, aims to evaluate the validity of laparoscopic intraoperative ultrasound (IOUS) in measuring rectosigmoid deep infiltrating endometriosis nodules. The primary objective is to determine the equivalence and agreement between nodule dimensions (expressed in millimeters) measured via postoperative histological examination-considered the gold standard-preoperative transvaginal ultrasound (TVUS), and laparoscopic intraoperative ultrasound performed after bowel mobilization (IOUS). Secondary objectives include analyzing potential systematic bias (overestimation or underestimation) of the ultrasound methods compared to histology, evaluating direct agreement between TVUS and IOUS, and conducting an exploratory analysis to verify whether factors such as lesion location, presence of adhesions, and nodule size influence measurement accuracy. The study plans to enroll a total of 20 adult female patients undergoing laparoscopic surgery for posterior compartment endometriosis with rectosigmoid involvement. The primary endpoint will be statistically analyzed using the Two One-Sided Tests (TOST) approach to test the equivalence of paired differences based on predefined margins, supported by descriptive analyses using the Intraclass Correlation Coefficient (ICC) and Bland-Altman methods.

03

Conditions studied

  • Endometriosis
  • Endometriosis Colon

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult women undergoing laparoscopic surgery for posterior compartment endometriosis with rectosigmoid involvement.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged ≥18 years;
  • Diagnosis of posterior compartment endometriosis with rectosigmoid involvement, with an indication for laparoscopic surgery;
  • Presence, during intraoperative examination, of a rectosigmoid endometriosis nodule amenable to excision via segmental resection;
  • Standardized preoperative transvaginal ultrasound with measurement of rectosigmoid nodule thickness;
  • Written .

Exclusion criteria

Exclusion Criteria:

  • Previous rectal resection or major colorectal surgery;
  • Absence of adequate histological sampling or histological report not evaluable for thickness;
  • Active pregnancy;
  • Refusal or inability to provide written .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testUltrasound contrast agent (Contrast-enhanced ultrasound)

    All patients will undergo standardized preoperative transvaginal ultrasound (TVUS) by expert operators to record nodule location, distance from the anal verge, and dimensions in three planes (longitudinal extension, transverse diameter, and depth of infiltration) in millimeters. During laparoscopic surgery, following complete rectosigmoid mobilization and lesion exposure, intraoperative ultrasound (IOUS) will be performed using an intracorporeal linear probe to measure the same three dimensions. The surgical specimen will then undergo standardized histological evaluation to assess maximum nodule thickness, depth of bowel wall infiltration, and associated fibrosis. Histological thickness measurement will serve as the gold standard for concordance analysis with TVUS and IOUS findings.

    Also known as: bowel resection

06

What researchers measure

Primary outcomes

  1. Equivalence between rectosigmoid endometriosis nodule dimensions.

    To evaluate the equivalence between rectosigmoid endometriosis nodule dimensions (mm) measured by TVUS and IOUS compared to the histological gold standard.

    Time frame: 6 months

Secondary outcomes

  1. The presence of systematic bias

    To evaluate the presence of systematic bias (overestimation/underestimation) of TVUS and IOUS measurements compared to histology

    Time frame: 6 months

  2. The agreement between TVUS and IOUS

    To assess the agreement between TVUS and IOUS

    Time frame: 6 months

  3. Potential influence of nodule location.

    To conduct an exploratory analysis of the potential influence of nodule location (rectum vs. sigmoid), presence of bowel adhesions, and nodule size on the obtained measurements.

    Time frame: 6 months

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Dec 2027, 14 months after the start.

Of 157 non-industry observational studies under Endometriosis, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's planned 14 months is below that.

Counting every sponsor, half of 184 studies reached it within 30 months; a quarter within 14 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 19, 2026
StartActual
Sep 21, 2026
Primary completionEst.
Dec 1, 2027
CompletionEst.
Jun 1, 2028
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07947459
Responsible party
Sponsor
First posted
Nov 19, 2026
Start date
Sep 21, 2026
Primary completion
Dec 1, 2027 (estimated)
Completion
Jun 1, 2028 (estimated)
Last update
Nov 19, 2026

Study contacts

Giorgia Gaia
principal investigator · Fondazione Policlinico Universitario A. Gemelli IRRCS

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion